Originally Published:Oct 13, 2024
Third Party Re-Publication by USA Citizens Network
Source: 2nd Smartest Guy in the World
by William Makis MD

BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published Sep.19, 2024! The future of Cancer Treatment starts now.

My Take…

This paper is the FIRST peer-reviewed and Published paper in the world to propose a Cancer Treatment Protocol based on the incredible properties of IVERMECTIN, MEBENDAZOLE (edit 2SG: this is the more expensive patented version that may in fact be inferior to Fenbendazole, totally needless, and simply represents BigPharma’s attempt to fleece sick patients) and FENBENDAZOLE.

This was truly a labor of love.

My thanks to lead authors Ilyes Baghli and Pierrick Martinez for their incredible inspired work, FLCCC’s Dr.Paul Marik for his extensive work on repurposed drugs and every co-author who worked hard to bring this paper to life.

I hope that this paper lays the groundwork for a brand new future for Cancer Treatment.

2SG’s Take…

This “brand new future” cancer treatment has been known for years by readers of this Substack.

The following protocol was initially conceived by this Substack as a desperately needed response to the slow kill bioweapon “vaccines” and their associated severe adverse events (SAE’s), such as turbo cancers and prion-based diseases; in fact, as this Substack continued its research, the following ‘cancer cure’ approach became a kind of treatment strategy for an ever broader range of ailments, as well as a powerful prophylaxis against viral infection, cancer, and even addresses the phenomenon of Long COVID, more at Long VAIDS (i.e. any Modified mRNA-induced damage, or any spike protein damage whether by infection, shedding or genetic modification) and environmental/dietary poisoning, which is now ubiquitous and also causes cancer and a whole host of neurological diseases, shortened lifespans, etc. & etc.

The Ultimate Disease Cure & Prophylaxis Protocol

• Tocotrienol and Tocopherol forms (all 8) of Vitamin E (400-800mg per day, 7 days a week). A product called Gamma E by Life Extension or Perfect E are both great.
• Bio-Available Curcumin (600mg per day, 2 pills per day 7 days a week). A product called Theracurmin HP by Integrative Therapeutics is bioavailable.
• Vitamin D (62.5 mcg [2500 IU] seven days a week).
• CBD oil (1-2 droppers full [equal to 167 to 334 mg per day] under the tongue, 7 days a week) CBD-X: The most potent full spectrum organic CBD oil, with 5,000 milligrams of activated cannabinoids and hemp compounds CBD, CBN & CBG per serving.
• Fenbendazole (450mg, 7 days a week) or in the case of severe turbo cancers up to 1 gram — for prophylaxis one 150mg tablet once or twice per week
• Ivermectin (24mg, 7 days a week) or in the case of severe turbo cancers up to 1mg/kg/day — for prophylaxis one 12mg tablet once or twice per week
• Hydroxychloroquine (10mg/kg/day 7 days a week) – for prophylaxis one 200mg tablet once or twice per week
• Doxycycline (100mg, 7 days a week for 30-60 days)
• ImmunX immune support which also greatly increases the bioavailability of both Fenbendazole and Hydroxychloroquine (2 capsules per day) — for prophylaxis 2 capsules per day
• Removing sugars and carbohydrates (cancer food) from your diet and replacing table sugar with a zero glycemic index, zero calorie, keto friendly rare sugar like AlluX

They want you dead.

Do NOT comply.

AI Assistance Disclosure:
This content was created with the assistance of AI tools for transcription, summarization, and formatting. All editorial selection, interpretation, and final publication decisions are made by the publisher. AI is used only as an assistive tool and does not replace human editorial oversight or responsibility.

Medical Information Disclaimer:
This content is for educational purposes only and is not medical advice. Consult a licensed professional.

Third-Party Re-Publication Notice:
This article is republished by USA Citizens Network for informational and public discussion purposes. The original content belongs to the original source.

Source Usage Notice:
Quotations or references may be included for commentary and educational analysis.